*Adjusted for age, sex, and ethnic background
†Adjusted for age, sex, ethnic background, socio-economic deprivation,
smoking, physical activity, alcohol consumption, BMI, SBP, DBP, HDL
cholesterol, LDL cholesterol, eGFR, COPD, diabetes mellitus, heart
failure, CHD, history of MI, history of stroke, use of low-dose aspirin,
use of lipid-lowering drugs, and number of drugs concurrently used.
Abbreviations: Covid-19 coronavirus disease 2019 OR odds
ratio CI confidence interval ARB angiotensin receptor
blocker CCB calcium-channel blocker BB beta-blockerRef. Reference
Figure Legends
Figure
1. Kaplan Meier curves of 28-day survival among all hypertensive
Covid-19 patients (A) and those hospitalized for Covid-19 (B) for
comparison of users of either CCB, BB or diuretics (solid line) and ACEI
(dash line).
Abbreviations: ACEI indicates angiotensin-converting enzyme inhibitor,
CCB calcium-channel blocker, BB beta-blocker
Figure
2. Kaplan Meier curves of 28-day survival among all hypertensive
Covid-19 patients (A) and those hospitalized for Covid-19 (B) for
comparison of users of either CCB, BB or diuretics (solid line) and ARB
(dash line).
Abbreviations: ARB indicates angiotensin receptor blocker, CCB
calcium-channel blocker, BB beta-blocker